Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update
Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update
Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update
Submitted by
admin
on October 28, 2015 - 9:38am
Source:
Motley Fool
News Tags:
Isis Pharmaceuticals
ISIS-GSK4-Lrx
GSK
Headline:
Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update
Do Not Allow Advertisers to Use My Personal information
